Mulmit

Xenetic Biosciences, Inc.Xenetic Biosciences, Inc.

XBIO Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-312,976,411-2,834,582-2,680,860-1.58
2024-12-312,500,284-4,204,428-3,960,275-2.57
2023-12-312,539,986-4,515,715-4,134,578-2.71
2022-12-311,706,925-6,717,908-6,552,353-4.61
2021-12-311,160,692-5,746,765-5,645,179-0.55

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-04-21PARSLOW JAMES FInterim CEO and CFO100,000
2025-12-31VINOGRADOV ALEXEY ANDREEVICH2,500
2025-12-31Dastoor Firdaus J.2,500
2025-12-31Kornberg Roger D.2,500
2025-12-31Borisenko Grigory G.2,500
2024-12-11Kornberg Roger D.2,500
2024-12-11Borisenko Grigory G.2,500
2024-12-11Dastoor Firdaus J.2,500
2024-12-11VINOGRADOV ALEXEY ANDREEVICH2,500
2024-06-18PARSLOW JAMES FInterim CEO and CFO20,000
2023-12-11PARSLOW JAMES FChief Financial Officer10,000
2023-12-11Lockshin CurtisChief Sciencific Officer10,000

8-K events

FiledItems
2026-08-07Results of operations · Financial statements and exhibits
2026-05-13Results of operations · Financial statements and exhibits
2026-04-24Officer or director change · Financial statements and exhibits
2026-03-13Results of operations · Financial statements and exhibits
2026-01-09Other events
2025-12-11Regulation FD disclosure · Financial statements and exhibits
2025-11-13Results of operations · Financial statements and exhibits
2025-10-14Entry into a material agreement · Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.